Compounded Bioidentical Hormone Therapy
For decades, women have turned to hormone replacement therapy to treat adverse vasomotor symptoms associated with menopause, such as hot flashes and night sweats.
Targeting Triple-Negative Breast Cancer
TNBC represents a challenge for both patients and clinicians due to its aggressive nature, and chemotherapy teamed with immunotherapy is the new standard of care.
One Impact of the COVID-19 Pandemic on the Pediatric Population: MIS-C
A severe inflammatory syndrome in children, multisystem inflammatory syndrome in children (MIS-C), that is associated with COVID-19 infection has been identified
PTA: Multisystem Inflammatory Syndrome in Children (MIS-C)
The CDC has issued a national health advisory for a newly emerging potential complication of COVID-19 in children and young adults called multisystem inflammatory syndrome in children (MIS-C). View a video about multisystem inflammatory syndrome in children (MIS-C).
PARP Inhibitors in Gynecologic Malignancies
The application of poly (ADP-ribose) polymerase (PARP) enzyme inhibitors for gynecologic malignancies—including ovarian, primary peritoneal, and fallopian tube carcinomas—have shown efficacy.
Screening and Cancer Survival Rates in Women
According to the CDC, combined 5-year survival for all cancer types was higher in women than in men, varying from a difference of 2.1% for thyroid cancer to 40% for lung and bronchus cancer.
Continuing Education
$6.97 Per CE Exam or $49 for 12 Lessons
-
Diabetes Management • November 2022 • 2.00 Credits
Population Health and Social Determinants of Health in Diabetes Management
-
Pediatric and Adolescent Health • October 2022 • 2.00 Credits
Epigenetics and Pharmacoepigenetics: Fine-Tuning Precision Medicine
-
Women's Health • September 2022 • 2.00 Credits
Uterine Fibroids Update for Pharmacists
Quick Poll
Copyright © 2000 - 2020 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.